Initiating Insulin Therapy in Type 1 Diabetes Mellitus
For patients with Type 1 Diabetes Mellitus, insulin therapy should be initiated with multiple daily injections of prandial and basal insulin at a starting dose of 0.5 units/kg/day, with approximately half as basal insulin and half as prandial insulin. 1
Initial Dosing Algorithm
Calculate Total Daily Insulin Dose:
Distribute the Total Daily Dose:
- Approximately 50% as basal insulin (long-acting)
- Approximately 50% as prandial insulin (rapid-acting) 1
Insulin Selection:
Administration Guidelines
- Basal insulin: Administer once daily at the same time each day 1
- Prandial insulin: Administer before meals, with timing based on:
- Insulin formulation pharmacokinetics
- Pre-meal blood glucose levels
- Carbohydrate content of meals 1
- Injection technique:
Dose Adjustment and Monitoring
- Titrate basal insulin based on fasting blood glucose levels, targeting 80-130 mg/dL 3
- Adjust prandial insulin doses based on:
- Carbohydrate counting (1 unit per 10-15g carbohydrate as starting point)
- Pre-meal blood glucose levels
- Anticipated physical activity 1
- Monitor blood glucose frequently during initiation and dose adjustments 2
- Evaluate HbA1c every 3 months to assess overall glycemic control 3
Education Components
- Carbohydrate counting: Teach patients to match prandial insulin to carbohydrate intake 1
- Hypoglycemia management: Ensure patients can recognize and treat hypoglycemia, and always carry quick-acting carbohydrates 3
- Sick day management: Provide guidelines for insulin adjustment during illness 1
- Exercise considerations: Educate on insulin adjustment for physical activity 3
Common Pitfalls and How to Avoid Them
- Nocturnal hypoglycemia: Use long-acting insulin analogs instead of NPH insulin, as they have lower risk of nocturnal hypoglycemia 1
- Intramuscular injection: Use short needles and proper injection technique to avoid IM delivery, which can cause unpredictable absorption and hypoglycemia 1
- Lipohypertrophy: Teach proper site rotation to prevent lipohypertrophy, which can lead to erratic insulin absorption 1
- Overbasalization: Monitor for signs of excessive basal insulin, including nocturnal hypoglycemia or high glucose variability 3
Advanced Options
For patients not meeting glycemic targets with multiple daily injections, consider:
- Continuous subcutaneous insulin infusion (insulin pump) 1
- Continuous glucose monitoring to improve glycemic control 1
- Automated insulin delivery systems for those capable of using the device safely 1
By following this structured approach to insulin initiation in Type 1 Diabetes, you can help patients achieve optimal glycemic control while minimizing the risks of hypoglycemia and other complications.